CodeMap® 




2017 ICD-10 Diagnosis Code Set Loaded     


4/3/2017 NCD Edits Loaded     


2017 Lab Fee Schedule     


2017-B DME Fee Schedule     


2017-A PEN Fee Schedule-no changes for Q2/2017     


2017 April ASC Fee Schedule Updated     


April 2017 ASP Drug Pricing Updated     


Q2 2017 CCI Edits Loaded     


Q2 2017 MUE Edits Loaded     


LCD Database Current Through 05/15/2017     

1901 North Roselle Road
Suite 640
Schaumburg, IL 60195
847-381-5465 Phone
847-381-4606 Fax
customerservice@codemap.com
      


User Information

Create New Account

Lost Password

Username:
Password:


Quick Links

Laboratory Fee Schedule

2017
2016

Physician Fee Schedule

2017
2016

OPPS Fee Schedule

2017
2016

ASC Fee Schedule

2017
2016

APC Codes

2017
2016

ASP Drug Pricing Files




Laboratory National Coverage Determinations
Recent NCD Manuals

Procedure
Policy Number
Title
Original Effective Date
Last Revised

80061 190.23 Lipids Testing11/25/2002 10/01/2011
80074 190.33 Hepatitis Panel/Acute Hepatitis Panel11/25/2002 10/01/2011
80162 190.24 Digoxin Therapeutic Drug Assay11/25/2002 10/01/2011
82105 190.25 Alpha-fetoprotein 11/25/2002 01/01/2012
82270 190.34 Fecal Occult Blood Test 11/25/2002 07/01/2008
82272 190.34 Fecal Occult Blood Test 11/25/2002 10/01/2011
82378 190.26 Carcinoembryonic Antigen 11/25/2002 10/01/2009
82438 190.5 Sweat Test10/01/2015 10/01/2015
82465 190.23 Lipids Testing11/25/2002 10/01/2011
82523 190.19 Collagen Crosslinks, Any Method11/25/2002 11/25/2002
82728 190.18 Serum Iron Studies 11/25/2002 10/01/2011
82947 190.20 Blood Glucose Testing 11/25/2002 10/01/2011
82948 190.20 Blood Glucose Testing 11/25/2002 10/01/2011
82962 190.20 Blood Glucose Testing 11/25/2002 10/01/2011
82977 190.32 Gamma Glutamyl Transferase 11/25/2002 10/01/2011
82985 190.21 Glycated Hemoglobin/Glycated Protein11/25/2002 10/01/2011
83036 190.21 Glycated Hemoglobin/Glycated Protein11/25/2002 10/01/2011
83540 190.18 Serum Iron Studies 11/25/2002 10/01/2011
83550 190.18 Serum Iron Studies 11/25/2002 10/01/2011
83700 190.23 Lipids Testing11/25/2002 10/01/2011
83701 190.23 Lipids Testing11/25/2002 10/01/2011
83704 190.23 Lipids Testing11/25/2002 10/01/2011
83718 190.23 Lipids Testing11/25/2002 10/01/2011
83721 190.23 Lipids Testing11/25/2002 10/01/2011
84153 190.31 Prostate Specific Antigen11/25/2002 10/01/2008
84436 190.22 Thyroid Testing11/25/2002 10/01/2011
84439 190.22 Thyroid Testing11/25/2002 10/01/2011
84443 190.22 Thyroid Testing11/25/2002 10/01/2011
84466 190.18 Serum Iron Studies 11/25/2002 10/01/2011
84478 190.23 Lipids Testing11/25/2002 10/01/2011
84479 190.22 Thyroid Testing11/25/2002 10/01/2011
84702 190.27 Human Chorionic Gonadotropin 11/25/2002 10/01/2011
85004 190.15 Blood Counts11/25/2002 4/1/2012
85007 190.15 Blood Counts11/25/2002 4/1/2012
85008 190.15 Blood Counts11/25/2002 4/1/2012
85013 190.15 Blood Counts11/25/2002 4/1/2012
85014 190.15 Blood Counts11/25/2002 4/1/2012
85018 190.15 Blood Counts11/25/2002 4/1/2012
85025 190.15 Blood Counts11/25/2002 4/1/2012
85027 190.15 Blood Counts11/25/2002 4/1/2012
85032 190.15 Blood Counts11/25/2002 4/1/2012
85048 190.15 Blood Counts11/25/2002 4/1/2012
85049 190.15 Blood Counts11/25/2002 4/1/2012
85610 190.17 Prothrombin Time (PT)11/25/2002 10/01/2011
85730 190.16 Partial Thromboplastin Time (PTT) 11/25/2002 10/01/2011
86300 190.29 Tumor Antigen by Immunoassay CA 15-3/CA 27.29 11/25/2002 10/01/2006
86301 190.30 Tumor Antigen by Immunoassay CA 19-911/25/2002 10/01/2006
86304 190.28 Tumor Antigen by Immunoassay CA 12511/25/2002 10/10/2006
86352 190.8 Lymphocyte Mitogen Response Assays10/01/2015 10/01/2015
86353 190.8 Lymphocyte Mitogen Response Assays10/01/2015 10/01/2015
86689 190.14 Human Immunodeficiency Virus (HIV) Testing (Diagnosis) 11/25/2002 10/01/2011
86701 190.14 Human Immunodeficiency Virus (HIV) Testing (Diagnosis) 11/25/2002 10/01/2011
86702 190.14 Human Immunodeficiency Virus (HIV) Testing (Diagnosis) 11/25/2002 10/01/2011
86703 190.14 Human Immunodeficiency Virus (HIV) Testing (Diagnosis) 11/25/2002 10/01/2011
86812 190.1 Histocompatibility Testing10/01/2015 10/01/2015
86813 190.1 Histocompatibility Testing10/01/2015 10/01/2015
86816 190.1 Histocompatibility Testing10/01/2015 10/01/2015
86817 190.1 Histocompatibility Testing10/01/2015 10/01/2015
86821 190.1 Histocompatibility Testing10/01/2015 10/01/2015
86822 190.1 Histocompatibility Testing10/01/2015 10/01/2015
86825 190.1 Histocompatibility Testing10/01/2015 10/01/2015
86826 190.1 Histocompatibility Testing10/01/2015 10/01/2015
87086 190.12 Urine Culture, Bacterial11/25/2002 10/01/2010
87088 190.12 Urine Culture, Bacterial11/25/2002 10/01/2010
87390 190.14 Human Immunodeficiency Virus (HIV) Testing (Diagnosis) 11/25/2002 10/01/2011
87391 190.14 Human Immunodeficiency Virus (HIV) Testing (Diagnosis) 11/25/2002 10/01/2011
87534 190.14 Human Immunodeficiency Virus (HIV) Testing (Diagnosis) 11/25/2002 10/01/2011
87535 190.14 Human Immunodeficiency Virus (HIV) Testing (Diagnosis) 11/25/2002 10/01/2011
87536 190.13 Human Immunodeficiency Virus (HIV) Testing (Prognosis Including Monitoring) 11/25/2002 10/01/2008
87537 190.14 Human Immunodeficiency Virus (HIV) Testing (Diagnosis) 11/25/2002 10/01/2011
87538 190.14 Human Immunodeficiency Virus (HIV) Testing (Diagnosis) 11/25/2002 10/01/2011
87539 190.13 Human Immunodeficiency Virus (HIV) Testing (Prognosis Including Monitoring) 11/25/2002 10/01/2008
88230 190.3 Cytogenetic Studies10/01/2015 10/01/2015
88233 190.3 Cytogenetic Studies10/01/2015 10/01/2015
88235 190.3 Cytogenetic Studies10/01/2015 10/01/2015
88237 190.3 Cytogenetic Studies10/01/2015 10/01/2015
88239 190.3 Cytogenetic Studies10/01/2015 10/01/2015
88240 190.3 Cytogenetic Studies10/01/2015 10/01/2015
88241 190.3 Cytogenetic Studies10/01/2015 10/01/2015
88245 190.3 Cytogenetic Studies10/01/2015 10/01/2015
88248 190.3 Cytogenetic Studies10/01/2015 10/01/2015
88249 190.3 Cytogenetic Studies10/01/2015 10/01/2015
88261 190.3 Cytogenetic Studies10/01/2015 10/01/2015
88262 190.3 Cytogenetic Studies10/01/2015 10/01/2015
88263 190.3 Cytogenetic Studies10/01/2015 10/01/2015
88264 190.3 Cytogenetic Studies10/01/2015 10/01/2015
88267 190.3 Cytogenetic Studies10/01/2015 10/01/2015
88269 190.3 Cytogenetic Studies10/01/2015 10/01/2015
88271 190.3 Cytogenetic Studies10/01/2015 10/01/2015
88272 190.3 Cytogenetic Studies10/01/2015 10/01/2015
88273 190.3 Cytogenetic Studies10/01/2015 10/01/2015
88274 190.3 Cytogenetic Studies10/01/2015 10/01/2015
88275 190.3 Cytogenetic Studies10/01/2015 10/01/2015
88280 190.3 Cytogenetic Studies10/01/2015 10/01/2015
88283 190.3 Cytogenetic Studies10/01/2015 10/01/2015
88285 190.3 Cytogenetic Studies10/01/2015 10/01/2015
88289 190.3 Cytogenetic Studies10/01/2015 10/01/2015
88291 190.3 Cytogenetic Studies10/01/2015
89230 190.5 Sweat Test10/01/2015 10/01/2015
G0103 210.1 Prostate Cancer Screening Tests11/25/2002 11/25/2002
G0123 210.2 Screening Pap Smears and Pelvic Examinations for Early Detection of Cervical or Vaginal Cancer11/25/2002 04/01/2007
G0124 210.2 Screening Pap Smears and Pelvic Examinations for Early Detection of Cervical or Vaginal Cancer11/25/2002 04/01/2007
G0141 210.2 Screening Pap Smears and Pelvic Examinations for Early Detection of Cervical or Vaginal Cancer11/25/2002 04/01/2007
G0143 210.2 Screening Pap Smears and Pelvic Examinations for Early Detection of Cervical or Vaginal Cancer11/25/2002 04/01/2007
G0144 210.2 Screening Pap Smears and Pelvic Examinations for Early Detection of Cervical or Vaginal Cancer11/25/2002 04/01/2007
G0145 210.2 Screening Pap Smears and Pelvic Examinations for Early Detection of Cervical or Vaginal Cancer11/25/2002 04/01/2007
G0147 210.2 Screening Pap Smears and Pelvic Examinations for Early Detection of Cervical or Vaginal Cancer11/25/2002 04/01/2007
G0148 210.2 Screening Pap Smears and Pelvic Examinations for Early Detection of Cervical or Vaginal Cancer11/25/2002 04/01/2007
G0248 190.11 Home Prothrombin Time INR Monitoring for Anticoagulation Management11/25/2002 03/19/2008
G0249 190.11 Home Prothrombin Time INR Monitoring for Anticoagulation Management11/25/2002 03/19/2008
G0250 190.11 Home Prothrombin Time INR Monitoring for Anticoagulation Management11/25/2002 03/19/2008
G0328 210.3 Colorectal Cancer Screening Tests11/25/2002 11/25/2002
G0432 210.7 Screening for the Human Immunodeficiency Virus (HIV) Infection07/06/2010 07/06/2010
G0433 210.7 Screening for the Human Immunodeficiency Virus (HIV) Infection07/06/2010 07/06/2010
G0435 210.7 Screening for the Human Immunodeficiency Virus (HIV) Infection07/06/2010 07/06/2010
G0464 210.3 Colorectal Cancer Screening10/09/2014 10/09/2014
P3000 210.2 Screening Pap Smears and Pelvic Examinations for Early Detection of Cervical or Vaginal Cancer11/25/2002 04/01/2007
P3001 210.2 Screening Pap Smears and Pelvic Examinations for Early Detection of Cervical or Vaginal Cancer11/25/2002 04/01/2007
Q0091 210.2 Screening Pap Smears and Pelvic Examinations for Early Detection of Cervical or Vaginal Cancer11/25/2002 04/01/2007

CodeMap® is a Registered Trademark of Wheaton Partners, LLC.